Posted inBiotechnology
Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Madrigal has paid Pfizer $50 million for the rights to a DGAT2i inhibitor with the intention of combining the drug…
Posted inMedical Technology
Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
Quanterix has a new chief executive and president in Everett Cunningham, but analysts at Leerink see Illumina’s former commercial chief…
Posted inBiotechnology
Baby KJ scientist launches personalized CRISPR therapy startup
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The…
Posted inBiotechnology
R-Loops Drive RNAPII Reprogramming in Early Development
In a groundbreaking study poised to reshape our understanding of early mammalian development, researchers have uncovered a pivotal role for…
Posted inBiotechnology
Youth Sarcopenia and Body Composition via Bioimpedance
In a groundbreaking advancement in pediatric health assessment, researchers have unveiled comprehensive bioelectrical impedance analysis (BIA) reference values tailored specifically…
Posted inBiotechnology
CircRNA14781 Drives Olaparib Resistance in Ovarian Cancer
In a groundbreaking study, researchers have uncovered the role of a specific circular RNA, CircRNA14781, in contributing to olaparib resistance…
Posted inBiotechnology
“CCL5/RANTES: Key to Inflammation Post-Mild TBI”
Recent studies have illuminated the intricate mechanisms of inflammation in the context of mild traumatic brain injury (mTBI), a condition…
Posted inBiotechnology
Calorie-Driven Weight Prediction Equation for Anorexia
In a groundbreaking study that underscores the complexities of nutritional psychology, a team of researchers has unveiled a novel calorie-based…
Posted inBiotechnology
Billy Crystal’s Lessons on Medicine and Interviews
In the ever-evolving world of medicine, one might wonder how seemingly unrelated elements—like the humor of a comedian—can influence the…
Posted inBiotechnology
Roche returns to MediLink with promise of $570M near-term payments for another ADC
Roche has got in on the B7-H3 action, agreeing to $570 million in near-term payments to existing partner MediLink Therapeutics…